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strate improved wound closure rates in these large ulcers
with STSGs, the price difference becomes negligible and
may favor using an STSG.
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PS184.
Compression Therapy Is Not Necessary After
Endovenous Ablation Therapy for the Treatment of
Varicose Veins
Angela Kokkosis, Harry Schanzer. Surgery, Mount Sinai
Medical Center, New York, NY
Objectives: Compression therapy is routinely used af-
ter endovenous saphenous ablation therapy (EVLT) for the
treatment of varicose veins. The rationale for compression
therapy is enhancement of vein closure and prevention of
superﬁcial thrombophlebitis (STP). A common patient
complaint postoperatively is the discomfort elicited by the
compression. The present work aims to determine whether
compression therapy is necessary as an adjunct to EVLT.
Methods: A total of 77 consecutive lower extremities
in 62 patients were treated with EVLT. Forty-two of the
treated extremities had postoperative compression, and
35 did not. All patients had duplex evaluation at 1 week af-
ter EVLT and then were clinically evaluated at 1 and 3
months. Primary end points were status of the treated
vein, presence or absence of STP, and the degree of vari-
cose vein resolution.
Results: There was no difference between compression
and no-compression groups in sex (63% vs 63% female), age
(59 vs 55 years), CEAP class (C2-C3, 81% vs 91%; C3-C4,
19% vs 9%), extent of varicose veins (<6 mm, 60% vs 66%;
>6 mm, 40% vs 34%), type of vein treated (great saphenous
vein, 80% vs 66%; small saphenous vein, 9% vs 20%; acces-
sory, 11% vs 14%) and operative variables. There was a
95% follow-up rate at 1 week, and all lower extremities
demonstrated saphenous vein closure. Three patients in
the compression group and no patients in the no-compres-
sion group had STP. No patients had deep venous throm-
bosis. At 1 month, both groups had the same rate of
varicose vein regression and need for secondary procedures.
Conclusions: Compression therapy does not add any
further beneﬁt to EVLT and therefore consideration
should be given to eliminating it, thus simplifying and
improving the postoperative recovery.
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Inferior Vena Cava Placement Utilization Among Over
250,000 Patients: National Trends, Complications,
and Relative Contraindications
Sapan S. Desai1, Anahita Dua2. 1Department of Surgery,
Duke University, Houston, Tex; 2Medical College of
Wisconsin, Milwaukee, WiscObjectives: The aim of this study was to evaluate
trends, complications, and risk factors that contribute to
morbidity associated with inferior vena cava (IVC) ﬁlter
placement.
Methods: A retrospective analysis of the National
Inpatient Sample (NIS), a 20% cross-section of all U.S.
inpatient admissions, was completed from 2000 to 2011
by identifying all patients who underwent IVC ﬁlter place-
ment (International Classiﬁcation of Diseases, Ninth Revi-
sion [ICD-9] 38.7). Complications including IVC
thrombosis (ICD-9 45.32) and death were determined.
Variables that were identiﬁed for each patient include
Agency for Healthcare Research and Quality (AHRQ)
standard comorbidities, clinical covariates including age,
gender, race, and insurance status. Propensity matching
was done to evaluate the effect of IVC ﬁlter placement
on reducing morbidity and mortality.
Results: A total of 251,295 patients (52% female)
were identiﬁed using the NIS, of which 2262 (0.9%) devel-
oped thrombosis of the IVC and 17,566 (7%) died. The
average age of admission was 66 years, 14% were elective
admissions. The rate of IVC thrombosis has decreased by
38% since 2000, paralleling the 50% decrease in mortality
over the same time period. Patients with comorbidities
including diabetes, hypertension, obesity, paralysis, chronic
obstructive pulmonary disease, renal failure, and heart dis-
ease were up to 2.3-times less likely to develop IVC throm-
bosis or die after receiving an IVC ﬁlter. Healthy men aged
<66 years were 2.2 times more likely to develop IVC
thrombosis after IVC ﬁlter placement. Overall, IVC ﬁlter
placement decreased morbidity from refractory deep vein
thrombosis and trauma by 30%.
Conclusions: IVC ﬁlter placement is effective in
reducing morbidity and mortality from deep vein throm-
bosis and trauma, particularly among patients aged >65
who have signiﬁcant comorbidities. However, IVC ﬁlter
placement among young, healthy men is disproportionately
associated with complications and its use should be re-eval-
uated among this population.
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Open Surgical vs Endovenous Ablation Treatment of
Patients with Klippel-Trenaunay Syndrome
Jennifer Fahrni, Peter Gloviczki, Manju Kalra, Mark D.
Fleming, Audra A. Duncan, Gustavo S. Oderich,
Haraldur Bjarnason, David Driscoll. Mayo Clinic,
Rochester, Minn
Objectives: To assess safety and efﬁcacy of open surgi-
cal treatment (OST) vs endovenous radiofrequency abla-
tion (RFA) in patients with Klippel-Trenaunay syndrome
(KTS).
Methods: Clinical data of all patients with complex
mixed venous malformation treated for chronic venous
insufﬁciency from 2008 to 2013 were reviewed. Perioper-
ative complications and outcome after OST and RFA
were compared.
Results: Twenty-seven limbs of 26 patients (14 fe-
males; mean age, 33 years; range, 15-74) were treated.
All had varicose veins, 59% had limb overgrowth, and
63% had capillary malformations. Three had previous
